Acute Lymphoblastic Leukemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Expanded Access to Ziftomenib
Conditions: Acute Lymphoblastic Leukemia, With Appropriate Mutations; Acute Myeloid Leukemia, With NPM1 Mutations Intervention: Drug: ziftomenib Sponsor: Kura Oncology, Inc. Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2023 Category: Research Source Type: clinical trials
